S.S. Popov

S.S. Popov

Auto-generated profile, based on publicly available information

S.S. Popov

Evogen LLC

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 April 2026 in S.S. Korsakov Journal of Neurology and Psychiatry
Verified
Journal Article
Closed access
ISInna Shamakina
Inna Shamakina
VKViktor Sergeevich Kokhan
Viktor Sergeevich Kokhan
VVV.A. Venkova
V.A. Venkova
VBV.YU. Baronets
V.YU. Baronets
SPS.S. Popov
S.S. Popov
PAPetr Anokhin
Petr Anokhin
As shown by a genome-wide association study (GWAS), the Bridging Integrator 1 (BIN1) gene is the second most important genetic locus associated with Alzheimer’s disease risk, after apolipoprotein E (APOE). Amphiphysin 2 (Bin1), encoded by this gene, is an adaptor protein involved in the regulation of synaptic vesicular transport and neurotransmission. In Alzheimer’s disease patients, Bin1 protein expression was found to be altered in several regions of the brain, including the hippocampus, which may affect Tau-dependent neurologic conditions and disease progression. This review presents current data on the structure, functions, and potential role of Bin1 in the pathogenesis of cognitive impairment of varying severity, as well as the potential use of allelic polymorphisms of the BIN1 gene for diagnosing cognitive impairment and assessing AD risk.